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BY-NC-ND license (http://creativecomBackground/Purpose: Epidemiology data of medical adverse events (MAEs) are crucial for pa-
tient safety policymaking. However, no epidemiological data on MAE exist in Taiwan. In this
study, we aimed to investigate the incidence of MAEs at a major medical center in northern
Taiwan.
Methods: The Harvard Medical Practice Study methodology was modified using a criterion-
based screening algorithm and critical medical record review process to investigate the risks
and incidences of MAEs. A Criterion-Based Screening for Medical Adverse Events (CBSMAE)
checklist was developed, and a three-tier strategy was applied to screen and review 2007 inpa-
tient hospitalizations from a single institution.
Results: A total of 2934 charts was sampled (Tier 1) and 950 possible MAEs were identified (Tier
2). One hundred and sixty-one probable MAE cases were subsequently critically reviewed (Tier
3). Nineteen (0.7%) MAE cases were confirmed. The MAEs involved 10 women and nine men
(mean age, 70 years). Most MAEs were from the surgery department [11 (57.9%) patients].have no conflicts of interest relevant to this article.
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Epidemiology of medical adverse events in Taiwan 435The major admission diagnoses were cardiac diseases [7 (36.8%) patients] with a cardiac prob-
lem [13 (31.7%) patients] as the major comorbidity. Major MAE attributes were a staff tech-
nique problem [12 (46.2%) patients] and patients’ underlying conditions (likelihood rating,
2.2). Eight (42.1%) patients required additional medical management, four (21.1%) patients
had a disability, and five (26.3%) patients had in-hospital mortality. Night MAEs (47.4%) were
considered preventable.
Conclusion: Surgical patients with cardiac conditions were at risk of MAE, particularly patients
who received invasive procedures. The epidemiology information from this study can serve as
baseline data to monitor a patient safety improvement campaign.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Patient safety is the core value of a healthcare organization
and has gradually emerged as a critical healthcare policy
issue worldwide since the release of medical error statistics
in the 1999 Institute of Medicine Report.1 The 2003 outbreak
of acute severe respiratory syndrome was a watershed in
Taiwan’s healthcare industry. The epidemic exposed the
vulnerability of the system with regard to poor infection
control, insufficient professional training, and lack of risk
management. Patient safety improvement has since become
a top priority in the nation’s healthcare policy agenda.
Incident reporting and management are the corner-
stones of patient safety.2 Since 2004, “encouragement of
incident reporting for medical adverse events (MAEs)” has
been listed in the national patient safety goals set by Tai-
wan’s Ministry of Health and Welfare. In 2005, the Taiwan
Joint Commission on Hospital Accreditation under the su-
pervision of the government began to develop the Taiwan
Patient-Safety Reporting System (TPRS) to provide a
nationwide MAE reporting and education platform.
TheWorldHealthOrganizaton (WHO)hasdefinedMAEasan
event that causes patients injuries frommedical errors suchas
misdiagnosis, malpractice, and device dysfunction, rather
than as a result of their own diseases.3 Medical adverse events
can be categorized as preventable (i.e., with negligence) or
unpreventable (i.e., without negligence). A “sentinel event”
is defined inmany countries aspatientmortality orpermanent
disability because of severe MAEs (e.g., incorrect blood type
being used in transfusions, surgical operations on incorrect
sites, inpatient suicides, or violence in the hospital). A “near
miss event” is defined as an event that could potentially have
caused harm but was stopped by inadvertent intervention or
immediate correction. A “no harm event” is an MAE that
causes no patient damage. Over the years, the TPRS has
recorded a considerable number of MAEs from acute, ambu-
latory, and chronic care facilities in Taiwan. The 2013 TPRS
annual report showed that 2.2% of MAEs may lead to severe
injuries or death in patients, and nearly 50% of healthcare
providers had experienced MAEs in their careers.4 However,
because the TPRS is based on voluntary, anonymousmerit and
lack an epidemiological basis, they likely do not reflect the
true patient safety status.5
In 1991, Leape et al6,7 developed a two-stage chart
review strategy in their Harvard Medical Practice Study(HMPS) to conduct epidemiological investigations of MAEs.
This methodology subsequently became the gold standard
in reporting the MAE incidence. For example, in 2000,
Thomas et al2 reported a 2.9% incidence of MAEs among 28
hospitals in the United States. In 2012, Wilson et al8 re-
ported that the incidence of MAEs was 8.2% among 26
hospitals in developing countries. Some other investigators
have estimated that the incidence of MAEs may range
2.9e16.6% per 100 discharged patients.9
However, the MAE epidemiological data of Taiwan remain
obscure. To allocate patient safety campaign resources and
monitor intervention effectiveness, policymakers and hos-
pital healthcare quality professionals must understand the
baseline MAE information.10 Therefore, the objective of this
study was to investigate the domestic MAE epidemiology in
Taiwan by using a modified HMPS methodology.
Methods
The study was conducted at the main Cathay General
Hospital (Taipei, Taiwan). The 900-bed hospital is an
academic-affiliated medical center located in downtown
Taipei that provides primary and tertiary referral care. This
project was approved by the Interview Review Board of
Cathay General Hospital. By adopting the HMPS chart re-
view methodology,6,7 a multidiscipline research team was
organized that consisted of physicians, nurses, and
healthcare managers to establish checklists and conduct
medical chart reviews for possible MAE. The MAE was
defined as an injury related to medical management rather
than to complications of disease. Medical management in-
cludes all aspects of care such as diagnosis and treatment,
failure to diagnose or treat, and the systems and equipment
used to deliver care.3 A 25-indicator Criterion-Based
Screening for Medical Adverse Events (CBSMAE) checklist
(Table 1) was developed to screen for possible MAE. A
Discharge Medical Adverse Event Checklist (DMAECL) was
also developed to document the specialty department,
admission diagnoses, comorbidities, causes, level of
disability, attributes, and preventability of MAEs. Based on
the WHO definition, the preventability of MAE was an
adverse event caused by error, systems failure, or equip-
ment failure.3
Based on the predetermined MAE occurrence rate of
10%, which was estimated from previous studies, a three-
Table 1 Criterion-based screening results for medical
adverse events in 19 patients.
No. (%)a
Transferred to ICU from general ward 8 (42.1)
Complication caused by procedure 7 (36.8)
Age <65 years & admitted during the
past year or age 65 years &
admitted during the past 6 months
6 (31.6)
In-hospital cardiac arrest 6 (31.6)
In-hospital mortality 5 (26.3)
Nosocomial infection 5 (26.3)
In-hospital CVA 3 (15.8)
Organ injury caused by
invasive procedure
3 (15.8)
Reoperation 3 (15.8)
Discharge without permission 2 (10.5)
2 ICU admissions 2 (10.5)
Fever >38.5 C 2 (10.5)
Transferred from other hospital 1 (5.3)
Readmission 1 (5.3)
Unplanned removal, injury,
or repair of an organ
1 (5.3)
New neurological sequence 1 (5.3)
Transferred to other acute care facility 0 (0.0)
In-hospital AMI 0 (0.0)
In-hospital pulmonary embolism 0 (0.0)
Birth incident or Apgar score <6 0 (0.0)
Adverse drug reaction 0 (0.0)
Medication error with injury 0 (0.0)
Accident injury 0 (0.0)
Transportation injury 0 (0.0)
Patient complaint 0 (0.0)
AMI Z acute myocardial infarction; CVA Z cerebrovascular
accident; ICU Z intensive care unit.
a Some patients may meet multiple criteria.
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methodology of HMPS (Figure 1) to screen a random sample
(10%) of 2960 inpatient hospitalization records (from 2007)
from the Cathay General Hospital. The medical records
were retrieved through systemic, stratified, and rational
sampling.
The first tier (Tier 1) screening for possible MAE was
systemically conducted by medical record administrators,
based on the CBSMAE criterion (Table 1). All sampled
medical charts were retrieved and categorized into three
groups: (1) no adverse events (NAE), (2) criterion met but
adverse event (AE) not likely (CMAENL), and (3) criterion
met and AE likely (CMAEL). Ten percent of the randomly
sampled NAE group medical charts, together with all
CMAENL and CMAEL charts, were subsequently collected for
the second tier (i.e., Tier 2) handling.
The second tier (Tier 2) was a cross-check for possible
MAE. The task was again conducted with a chart review by
two experienced nurse practitioners, based on the same
CBSMAE criterion used in Tier 1. All reviewers were trained
to use the checklist to ensure review validity and consis-
tency. When there was a discrepancy in identifying possible
MAEs, the two reviewers would retrieve the medical charts
for cross-check, and then send them for a third-tier review.Cases from Tier 1 were all reviewed and again catego-
rized into three subgroups: (1) NAE, (2) criterion met AE but
discrepant judgment (CMAEDJ) between the two reviewers,
and (3) CMAEL. Ten percent of the randomly sampled NAE
group medical charts, together with all of the CMAEDJ and
CMAEL charts, were subsequently collected for third-tier
(i.e., Tier 3) handling.
The third tier (Tier 3) was an expert review of probable
MAEs. The critical review was conducted by senior physi-
cians using a CBSMAE checklist on the 10% NAE, CMAEDJ,
and CMAEL charts from Tier 2. The DMAECL checklist was
used to confirm the presence of medical errors.
The MAE profile details such as admission diagnoses,
general health conditions, comorbidities, causes and types
of MAEs, and outcomes (i.e., end-of-follow-up health status,
injury, or quality-of-life impact) were then documented for
analysis. We used the recommended taxonomy of the WHO
Alliance for Patient Safety draft guidelines to classify the
causes and types of MAEs (technique, procedure, diagnosis,
medication, infusion, systemic evaluation, etc.).3
The c2 test was used to compare the incidence of MAEs
between different age groups (<65 years and 65 years).
A p < 0.05 was considered statistically significant.Results
A total of 2960 discharge records were retrieved after
randomized sampling (10%) from all admissions. Repeated
sampling was allowed for some patients. A total of 2934
medical records were criterion-based screened (Tier 1) by
medical record administrators; 950 possible MAEs were
cross-checked (Tier 2) by two nurse practitioners. One
hundred and sixty-one probable MAEs were critically
reviewed (Tier 3) by physician reviewers. The critical
review confirmed 19 (0.7%) MAEs. The screening and review
algorithm is shown in Figure 1.
The criterion-based screening showed that being trans-
ferred to an intensive care unit (ICU) from a general ward
(because a patient’s condition changed); complications
caused by a procedure; age < 65 year and being admitted
within the past year or age  65 years and being admitted
during the past 6 months, in-hospital cardiac arrest, in-
hospital mortality, nosocomial infection, in-hospital cere-
bral vascular accident (CVA), organ injury caused by an
invasive procedure, and reoperation were common types of
MAE (Table 1).
The 19 MAEs were experienced by 10 women and nine
men (mean age, 70  9 years). Most patients were from the
surgery department [11 (57.9%) patients]. The major
admission diagnoses of patients who had these MAEs were
cardiac diseases [7 (36.8%) patients], and the major co-
morbidity was a cardiac problem [13 (31.7%) patients]. Most
MAEs occurred during the index hospitalization [16 (84.2%)
patients] and in the inpatient ward [8 (42.1%) patients;
Table 2].
We found that a staff technique problem [12 (46.2%)
cases] was the major cause of MAE. The major attribute of
MAE was a staff personal factor with a likelihood rating of
2.2  0.5 (expressed as the mean  the standard error).
Eight (42.1%) patients required additional medical atten-
tion and prolonged hospitalization, four (21.1%) patients
Figure 1 Medical adverse event screening and review algorithm. AE Z Adverse events.
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direct consequence of MAEs (Table 3).
The statistics showed that all-cause MAEs were more
likely to occur in patients older than 65 years (Table 4).
Nine (47.4%) MAEs were considered preventable after chart
reviews by physician reviewers.
Discussion
Patient safety has been ranked as the highest priority in
Taiwan’s healthcare policy agenda since the beginning of
the 21st century; however, the safety status of Taiwan’s
healthcare facilities remains unknown. Tense patient-
ephysician relationships, distrust, and ever-escalating
medicolegal lawsuits are widely considered major factors
that frustrate healthcare workers and drive them out of
clinical practice.11,12 Professionals and the public are
anxious to understand the current patient safety status. In
addition, to allocate healthcare administration resources,
policymakers and healthcare executives have had to
monitor the effectiveness of relentless patient safety
campaigns in the past few years.
Understanding patient safety status is impossible
without reliable MAE epidemiological data. The increase of
incident reporting is a consequence of policy promotion and
a change in patient safety climate rather than a deterio-
ration in the safety status. Accepted patient indicators such
as patient falls, pressure ulcers, and readmissions may not
reflect the entire patient safety condition.
However, the investigation of MAE epidemiology requires
substantial research resources. Themethodology establishedby the HMPS involves multiple centers that require funding
support from regional governments.6,7 In this decade, the
Institute for Healthcare Improvement developed the Global
Trigger Tool to rapidly assess MAE frequency by indicators.6,7
The reported MAE incidences may range 2.9e16.6%, as re-
ported by Brennan et al6 and Aranaz-Andre´s et al.13
Limited MAE epidemiology data have been compiled for
Taiwan and Asia. Our study is the first of this type in Taiwan
to show the incidence of MAE from a single institute. The
investigated period (i.e., the year 2007) was nearly a
decade after the global initiation of the patient safety
campaign; by that time many safety protocols had become
standard in daily hospital operation. This finding may
explain why our MAE of 0.7% was lower than the incidence
reported by most previous early reports. However, our data
(e.g., patient mean age of 70 years) are compatible with
the findings reported by Aranaz-Andre´s et al13,14 and Zegers
et al15 in which most MAEs occurred in patients older than
65 years. Furthermore, most MAEs in our study occurred in
surgical patients and were caused by staff technique
problems. Procedure or surveillance failure are also critical
in MAEs, and our findings are partly compatible with the
data published by Wilson et al8 and others.13,16,17
Only 21.1% (4 cases) of patients who experienced a MAE
had permanent disabilities in this study; however, we
observed that patients with multiple comorbidities may
incur further severe medical consequences that require
considerable medical attention with additional procedures
or extended hospitalization.
The preventability of MAEs often refers to the presence
of negligence. The MAE preventability of 47.4% in
Table 2 Clinical service, admission diagnosis, comor-
bidity, time, and site of medical adverse events in 19
patients.
Clinical service No. (%)
Surgery 11 (57.9)
Internal medicine 7 (36.8)
Obstetrics & gynecology 1 (5.3)
Admission diagnosis
(by organ system)
No. (%)
Cardiology 7 (36.8)
Urology 2 (10.5)
Cardiovascular surgery 1 (5.3)
Endocrine & metabolism 1 (5.3)
Otorhinolaryngology 1 (5.3)
Gastroenterology 1 (5.3)
General surgery 1 (5.3)
Obstetrics & gynecology 1 (5.3)
Infection 1 (5.3)
Nephrology 1 (5.3)
Neurosurgery 1 (5.3)
Orthopedics 1 (5.3)
Comorbidity No.
(frequency [%])a
Cardiac 13 (31.7)
Endocrine & metabolic 10 (24.4)
Renal 6 (14.6)
Respiratory 3 (7.3)
Existing cancer 3 (7.3)
Neurological 2 (4.9)
Gastrointestinal 1 (2.4)
Bone/joint disorder 1 (2.4)
Others 2 (4.9)
Time of occurrence No. (%)
Occurred during index
hospitalization
16 (84.2)
Occurred during earlier
hospitalization
3 (15.8)
Site of occurrence No. (%)
Outpatient physician office 1 (5.3)
Inpatient ward 8 (42.1)
Examination room 3 (15.8)
Operation room 7 (36.8)
a Some cases may meet multiple criteria.
Table 3 Causes, attributes, and outcomes of medical
adverse events in 19 patients.
Causes of adverse eventsa No. (frequency [%])a
Technique problem 12 (46.2)
Procedure or surveillance
failure
4 (15.4)
Infection 3 (11.4)
Failure or delayed diagnosis 2 (7.8)
Medication, infusion, or
transfusion problem
2 (7.8)
Poor systemic evaluation 2 (7.8)
Others 1 (3.8)
Attribute of adverse event Likelihood ratingb
Individual patient factor 1.3  0.5
Work factor 1.1  0.4
Staff personal factor 2.2  0.5
Team factor 1.9  0.5
Work environment 0.1  0.1
Organization or management
factor
0.2  0.1
Outcome of adverse event No. (%)
Extra medical management/
extended admission
8 (42.1)
Permanent disability 4 (21.1)
Death 5 (26.3)
No damage 2 (10.6)
a Some patients may meet multiple criteria.
b The values are expressed as the mean  the standard error,
range (0e7), as rated by reviewers.
Table 4 Age effect on the incidence of medical adverse
events.a
Age <65 y
(N Z 6)
Age  65 y
(N Z 13)
p
Site of occurrence & & <0.001
Outpatient physician
office
0 1.2
Inpatient ward 0.9 7.4
Examination room 0.5 0
Operation room 1.4 4.9
Causes of adverse
eventsb
& & <0.001
Technique problem 2.4 8.8
Procedure or
surveillance failure
0.9 2.5
Infection 0.5 2.5
Failure or delayed
diagnosis
0 2.5
Medication, infusion, or
transfusion problem
0 2.5
Poor systemic
evaluation
0 2.5
Others 0.5 0
a The < 65 years age group had 2120 medical chart reviews
and the 65 years age group had 814 reviews.
b Some patients may meet multiple criteria.
438 C.-H. Wang et al.this study is similar to the 42.8e69.6% reported by
others,13,18 which indicates that patient safety works can
be improved further through systemic and proactive
measures.
The exploration and generalizability of this study were
restricted by its single-institute and cross-sectional
approach. The comparability of the data was limited
by the lack of case-mix adjustments among the studies.
The MAE epidemiological data presented in this article also
do not reflect the current patient safety status nation-
wide. Nevertheless, monitoring changes in patient safety
status requires longitudinal epidemiological data. We
believe this study can provide useful baseline data to
determine the effectiveness of patient safety intervention
in the future.
Epidemiology of medical adverse events in Taiwan 439Conclusion
The incidence of in-hospital MAEs was 0.7% in this study.
This retrospective review suggested that age, change in
patient condition, procedure-induced complications, and
previous admission were risk factors for MAE occurrence,
particularly in surgical patients. The epidemiological
information can serve as baseline data to monitor the
effectiveness and progress of an institution-wide patient
safety improvement campaign.
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